Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
Company codeEKSO
Company nameEkso Bionics Holdings Inc
IPO dateApr 10, 2013
Founded at2012
CEOMr. Scott G. Davis
Number of employees61
Security typeOrdinary Share
Fiscal year-endApr 10
Address101 Glacier Point
CitySAN RAFAEL
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code94901
Phone15109841761
Websitehttps://eksobionics.com/
Company codeEKSO
IPO dateApr 10, 2013
Founded at2012
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data